tiprankstipranks
Trending News
More News >
X4 Pharmaceuticals (XFOR)
NASDAQ:XFOR
US Market

X4 Pharmaceuticals (XFOR) Stock Forecast & Price Target

Compare
1,111 Followers
See the Price Targets and Ratings of:

XFOR Analyst Ratings

Currently, no data available
Based on NaN analysts giving stock ratings to
X4
Pharmaceuticals
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

XFOR Stock 12 Month Forecast

There Are No Analyst Ratings for XFOR In The Last 3 Months.
Highest Price TargetAverage Price TargetLowest Price Target
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

XFOR Financial Forecast

XFOR Earnings Forecast

Currently, no earnings data available.
Currently, no earnings data available.

XFOR Sales Forecast

Currently, no sales data available.
Currently, no sales data available.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Guggenheim Analyst forecast on XFOR
Guggenheim
Guggenheim
$12
Buy
252.94%
Upside
Initiated
03/09/26
X4 Pharmaceuticals initiated with a Buy at GuggenheimX4 Pharmaceuticals initiated with a Buy at Guggenheim
Stifel Nicolaus Analyst forecast on XFOR
Stifel Nicolaus
Stifel Nicolaus
$7.5$10
Buy
194.12%
Upside
Initiated
12/05/25
X4 Pharmaceuticals price target raised to $10 from $7.50 at StifelX4 Pharmaceuticals price target raised to $10 from $7.50 at Stifel
Cantor Fitzgerald Analyst forecast on XFOR
Cantor Fitzgerald
Cantor Fitzgerald
$14
Buy
311.76%
Upside
Reiterated
11/21/25
Cantor Fitzgerald Keeps Their Buy Rating on X4 Pharmaceuticals (XFOR)
H.C. Wainwright Analyst forecast on XFOR
H.C. Wainwright
H.C. Wainwright
$3.5$5
Buy
47.06%
Upside
Reiterated
11/10/25
X4 Pharmaceuticals price target raised to $5 from $3.50 at H.C. WainwrightX4 Pharmaceuticals price target raised to $5 from $3.50 at H.C. Wainwright
Brookline Capital Markets Analyst forecast on XFOR
Brookline Capital Markets
Brookline Capital Markets
$120
Buy
3429.41%
Upside
Reiterated
03/25/25
Brookline Capital Markets reiterates Buy Rating on X4 Pharmaceuticals (XFOR)Brookline Capital Markets analyst Leah Rush Cann reiterated a Buy rating and $4.00 price target on X4 Pharmaceuticals (NASDAQ: XFOR).
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Guggenheim Analyst forecast on XFOR
Guggenheim
Guggenheim
$12
Buy
252.94%
Upside
Initiated
03/09/26
X4 Pharmaceuticals initiated with a Buy at GuggenheimX4 Pharmaceuticals initiated with a Buy at Guggenheim
Stifel Nicolaus Analyst forecast on XFOR
Stifel Nicolaus
Stifel Nicolaus
$7.5$10
Buy
194.12%
Upside
Initiated
12/05/25
X4 Pharmaceuticals price target raised to $10 from $7.50 at StifelX4 Pharmaceuticals price target raised to $10 from $7.50 at Stifel
Cantor Fitzgerald Analyst forecast on XFOR
Cantor Fitzgerald
Cantor Fitzgerald
$14
Buy
311.76%
Upside
Reiterated
11/21/25
Cantor Fitzgerald Keeps Their Buy Rating on X4 Pharmaceuticals (XFOR)
H.C. Wainwright Analyst forecast on XFOR
H.C. Wainwright
H.C. Wainwright
$3.5$5
Buy
47.06%
Upside
Reiterated
11/10/25
X4 Pharmaceuticals price target raised to $5 from $3.50 at H.C. WainwrightX4 Pharmaceuticals price target raised to $5 from $3.50 at H.C. Wainwright
Brookline Capital Markets Analyst forecast on XFOR
Brookline Capital Markets
Brookline Capital Markets
$120
Buy
3429.41%
Upside
Reiterated
03/25/25
Brookline Capital Markets reiterates Buy Rating on X4 Pharmaceuticals (XFOR)Brookline Capital Markets analyst Leah Rush Cann reiterated a Buy rating and $4.00 price target on X4 Pharmaceuticals (NASDAQ: XFOR).
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering X4 Pharmaceuticals

3 Months
xxx
Success Rate
6/15 ratings generated profit
40%
Average Return
-17.95%
reiterated a xxx
rating 4 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 40.00% of your transactions generating a profit, with an average return of -17.95% per trade.
1 Year
Leah R. CannBrookline Capital Markets
Success Rate
4/17 ratings generated profit
24%
Average Return
-28.95%
reiterated a buy rating 12 months ago
Copying Leah R. Cann's trades and holding each position for 1 Year would result in 23.53% of your transactions generating a profit, with an average return of -28.95% per trade.
2 Years
xxx
Success Rate
2/15 ratings generated profit
13%
Average Return
-62.62%
reiterated a xxx
rating 4 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 13.33% of your transactions generating a profit, with an average return of -62.62% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

XFOR Analyst Recommendation Trends

Rating
Nov 25
Dec 25
Jan 26
Feb 26
Mar 26
Strong Buy
5
4
3
1
1
Buy
2
2
1
0
0
Hold
0
1
8
9
8
Sell
2
0
1
1
1
Strong Sell
0
0
0
0
0
total
9
7
13
11
10
In the current month, XFOR has received 1 Buy Ratings, 8 Hold Ratings, and 1 Sell Ratings. XFOR average Analyst price target in the past 3 months is .
Each month's total comprises the sum of three months' worth of ratings.

XFOR Stock Forecast FAQ

What is XFOR’s average 12-month price target, according to analysts?
Currently, no data Available
What is XFOR’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for XFOR, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is XFOR a Buy, Sell or Hold?
      Currently, no data Available
      What is X4 Pharmaceuticals’s price target?
      Currently, no data Available
      What do analysts say about X4 Pharmaceuticals?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of XFOR?
      Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.